Polyrizon Ltd. Ordinary Shares

PLRZ XNAS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

31M

Short interest (Jul 15)

2.4%

Net Short (Jul 27 ): 0.2%

Borrow Fee

66.10%

↓ 16.1%

Available Shares

200K

↓ 20.0%

Price Chart

Company Overview

Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.

Company Info

Exchange: NASDAQ

CIK: 0001893645

Asset Type: CS

Market Data

Market Cap: $30,592,811

Employees: 1

Status: Active

Short Interest

Current Borrow Fee 66.10%

Range: 66.10% - 76.10%

Available Shares 200K

Range: 100K - 200K

Recent Changes

Fee Change: ↓ 7.8%

Available Change: ↓ 14.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime